Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

NCT05175625 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
BIOLOGICAL: Saline placebo

Sponsor

Cinnagen

Collaborators

[object Object]